mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
      • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
      • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
How AI is Shaping the Future of MedTech - a new special report
Joanna Smith - February 27, 2025

How AI is Shaping the Future of MedTech - a new special report

We are delighted to release our latest report How AI is Shaping the Future of MedTech. View the ...

Quantum and the law - a new special report
Joanna Smith - January 14, 2025

Quantum and the law - a new special report

We are delighted to release our latest report Quantum and the law. View the report here.

Phasecraft: the pioneer in quantum software
Andrew Fearnside - September 2, 2024

Phasecraft: the pioneer in quantum software

The Bristol and London company, which has recently opened an office in Washington DC, is a world ...

Inside Silicon Quantum Computing: an interview with Komal Pahwa
Andrew Fearnside - March 6, 2024

Inside Silicon Quantum Computing: an interview with Komal Pahwa

Senior IP counsel Komal Pahwa reveals how Australia's star quantum startup is building a silicon ...

The world beyond quantum computing
Andrew Fearnside - August 21, 2023

The world beyond quantum computing

Infleqtion is developing the next generation of quantum tools, including clocks, gravimeters and ...

The state of quantum
Andrew Fearnside - December 15, 2022

The state of quantum

Quantum chips are sparking into life. But what is this hardware going to be used for?

Quantum and the law
Andrew Fearnside - December 15, 2022

Quantum and the law

Mewburn Ellis speaks to Kaniah Konkoly-Thege, Chief Legal Officer and Head of Government Relations ...

UK Government expands R&D Tax Relief to cover Quantum, AI and Robotics research
Andrew Fearnside - May 5, 2022

UK Government expands R&D Tax Relief to cover Quantum, AI and Robotics research

The recently published 2022 Spring Statement1 indicates support for a “new culture of enterprise” ...

The NISQ-era: a quantum stepping-stone
Andrew Fearnside - April 7, 2022

The NISQ-era: a quantum stepping-stone

In our previous blog, ‘Noisy quantum computing: overcoming quantum decoherence’, we discussed how ...

A trillion times more powerful: the race to produce the world's first quantum computer chip
Andrew Fearnside - March 30, 2022

A trillion times more powerful: the race to produce the world's first quantum computer chip

Meet the British startup on the brink of winning the race to produce the world's first ...

Venturing ahead: helping Munich make its name in quantum tech
Andrew Fearnside - November 17, 2021

Venturing ahead: helping Munich make its name in quantum tech

Christopher Trummer, managing director of the TUM Venture Lab Quantum, explains why ...

Quantum System One: is Europe ready?
Andrew Fearnside - August 5, 2021

Quantum System One: is Europe ready?

With quantum start-ups now appearing across the globe and tech giants such as IBM edging ever ...

Creating qubits: Making progress with photonics
Andrew Fearnside - July 7, 2021

Creating qubits: Making progress with photonics

Forward spoke with Jelmer Renema of Dutch firm QuiX about why photonics technology has so much ...

Creating qubits: a hot lead at ColdQuanta
Andrew Fearnside - May 11, 2021

Creating qubits: a hot lead at ColdQuanta

Mark Saffman tells Forward why an atomic approach has all the hallmarks of a winning quantum ...

Shock treatment: what’s behind the race to crack quantum?
Andrew Fearnside - April 15, 2021

Shock treatment: what’s behind the race to crack quantum?

As the UK begins work towards realising world-beating ambitions, Forward set out to learn just what ...

PsiQuantum expect commercial quantum computer by 2025
Andrew Fearnside - March 29, 2021

PsiQuantum expect commercial quantum computer by 2025

By 2025, the team from secretive quantum computing firm PsiQuantum will have a commercial quantum ...

Quantum braiding: an introduction to topological quantum computing
Andrew Fearnside - November 18, 2020

Quantum braiding: an introduction to topological quantum computing

In our previous blog, ‘Noisy quantum computing: overcoming quantum decoherence’, we discussed the ...

Britain launches largest industry-led project to commercialise the use of quantum computing
Andrew Fearnside - November 6, 2020

Britain launches largest industry-led project to commercialise the use of quantum computing

On 6 November 2020, Britain launched its largest industry-led quantum computing project, DISCOVERY, ...

Post-quantum cryptography – a new hope
Andrew Fearnside - September 9, 2020

Post-quantum cryptography – a new hope

The race to build a large-scale quantum computer is one of the most exciting technology challenges ...

Noisy quantum computing: overcoming quantum decoherence
Andrew Fearnside - September 8, 2020

Noisy quantum computing: overcoming quantum decoherence

Anticipated as the next great leap in human technology, quantum computing promises to revolutionise ...

Quantum computing: Why qubits have consequences for IP
Andrew Fearnside - August 17, 2020

Quantum computing: Why qubits have consequences for IP

As part of our Thought Leaders series, Mewburn Ellis Senior Associate Andrew Fearnside explores ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy